Jupiter Research Capital (Asia) Ltd’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMLX
SVCM
Jupiter Research Capital (Asia) Ltd's AMLX Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd opened a new position in Amylyx Pharmaceuticals (AMLX) in Q3 2026: 15,004 shares worth $437K. The stake represents 0.05% of the portfolio and ranks #379 among its holdings. This is a return to the name: Jupiter Research Capital (Asia) Ltd previously reported a position in AMLX as recently as Q4 2025.
Jupiter Research Capital (Asia) Ltd first reported a position in AMLX in Q4 2025 and has held it in 2 quarters since. The position peaked at $519K in Q4 2025. 216 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd held 15,004 shares of Amylyx Pharmaceuticals worth $437K as of Q3 2026.
- Amylyx Pharmaceuticals was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
- Amylyx Pharmaceuticals made up 0.05% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #379 holding.
- Jupiter Research Capital (Asia) Ltd first reported a position in Amylyx Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
- Jupiter Research Capital (Asia) Ltd's Amylyx Pharmaceuticals position peaked at $519K in Q4 2025.
- 216 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.